Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

January 15, 2022; Volume 19,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Binder, Hans

    1. You have access
      Single-cell trajectories of melanoma cell resistance to targeted treatment
      Maria Schmidt, Lena Sünke Mortensen, Henry Loeffler-Wirth, Corinna Kosnopfel, Knut Krohn, Hans Binder and Manfred Kunz
      Cancer Biology & Medicine January 2022, 19 (1) 56-73; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0267
  2. Cheng, Xi

    1. You have access
      Drug repurposing for cancer treatment through global propagation with a greedy algorithm in a multilayer network
      Xi Cheng, Wensi Zhao, Mengdi Zhu, Bo Wang, Xuege Wang, Xiaoyun Yang, Yuqi Huang, Minjia Tan and Jing Li
      Cancer Biology & Medicine January 2022, 19 (1) 74-89; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0218
  3. Cui, Ming

    1. You have access
      Commensal microbiota in the digestive tract: a review of its roles in carcinogenesis and radiotherapy
      Jiali Dong, Yuan Li, Huiwen Xiao, Ming Cui and Saijun Fan
      Cancer Biology & Medicine January 2022, 19 (1) 43-55; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0476
  4. Dong, Jiali

    1. You have access
      Commensal microbiota in the digestive tract: a review of its roles in carcinogenesis and radiotherapy
      Jiali Dong, Yuan Li, Huiwen Xiao, Ming Cui and Saijun Fan
      Cancer Biology & Medicine January 2022, 19 (1) 43-55; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0476
  5. Dou, Hao

    1. You have access
      CUL4B facilitates HBV replication by promoting HBx stabilization
      Haixia Shan, Bo Wang, Xiaodong Zhang, Hui Song, Xi Li, Yongxin Zou, Baichun Jiang, Huili Hu, Hao Dou, Changshun Shao, Lifen Gao, Chunhong Ma, Xiaoyun Yang, Xiaohong Liang and Yaoqin Gong
      Cancer Biology & Medicine January 2022, 19 (1) 120-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0468
  6. Fan, Saijun

    1. You have access
      Commensal microbiota in the digestive tract: a review of its roles in carcinogenesis and radiotherapy
      Jiali Dong, Yuan Li, Huiwen Xiao, Ming Cui and Saijun Fan
      Cancer Biology & Medicine January 2022, 19 (1) 43-55; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0476
  7. Fang, Tingting

    1. You have access
      Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway
      Mingyan He, Jing Hu, Tingting Fang, Wenqing Tang, Bei Lv, Biwei Yang and Jinglin Xia
      Cancer Biology & Medicine January 2022, 19 (1) 90-103; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0313
  8. Gao, Guanfeng

    1. You have access
      The biogenesis, function and clinical significance of circular RNAs in breast cancer
      Yan Zeng, Yutian Zou, Guanfeng Gao, Shaoquan Zheng, Song Wu, Xiaoming Xie and Hailin Tang
      Cancer Biology & Medicine January 2022, 19 (1) 14-29; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0485
  9. Gao, Lifen

    1. You have access
      CUL4B facilitates HBV replication by promoting HBx stabilization
      Haixia Shan, Bo Wang, Xiaodong Zhang, Hui Song, Xi Li, Yongxin Zou, Baichun Jiang, Huili Hu, Hao Dou, Changshun Shao, Lifen Gao, Chunhong Ma, Xiaoyun Yang, Xiaohong Liang and Yaoqin Gong
      Cancer Biology & Medicine January 2022, 19 (1) 120-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0468
  10. Gong, Yaoqin

    1. You have access
      CUL4B facilitates HBV replication by promoting HBx stabilization
      Haixia Shan, Bo Wang, Xiaodong Zhang, Hui Song, Xi Li, Yongxin Zou, Baichun Jiang, Huili Hu, Hao Dou, Changshun Shao, Lifen Gao, Chunhong Ma, Xiaoyun Yang, Xiaohong Liang and Yaoqin Gong
      Cancer Biology & Medicine January 2022, 19 (1) 120-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0468
« Previous (Pages : 1 2 3 4 5 6 ... 7) Next »
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (1)
Cancer Biology & Medicine
Vol. 19, Issue 1
15 Jan 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire